Literature DB >> 9396053

Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period.

J Y Wu1, K A Henins, P Gressens, I Gozes, M Fridkin, D E Brenneman, J M Hill.   

Abstract

Previous work has shown that blockade of VIP function in the early postimplantation embryo results in growth retardation and microcephaly. In the present work, the neurobehavioral development of neonatal mice was examined following treatment of dams with a VIP antagonist during this period. Inhibition of VIP functions during early embryogenesis impaired the performance of 5 of 10 developmental behaviors. These behaviors included developmental milestones (first appearance of ear twitch and eye opening) and complex motor behaviors (negative geotaxis, surface righting, and air righting). The retardation of neurobehavioral development produced by inhibition of VIP action indicates that this peptide is important to the progression of embryonic development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396053     DOI: 10.1016/s0196-9781(97)00146-0

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  15 in total

1.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

2.  A glia-derived signal regulating neuronal differentiation.

Authors:  O Blondel; C Collin; W J McCarran; S Zhu; R Zamostiano; I Gozes; D E Brenneman; R D McKay
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

3.  Long-term Reductions in the Population of GABAergic Interneurons in the Mouse Hippocampus following Developmental Ethanol Exposure.

Authors:  Clark W Bird; Devin H Taylor; Natalie J Pinkowski; G Jill Chavez; C Fernando Valenzuela
Journal:  Neuroscience       Date:  2018-05-15       Impact factor: 3.590

4.  Altered social behavior in mice carrying a cortical Foxp2 deletion.

Authors:  Vera P Medvedeva; Michael A Rieger; Beate Vieth; Cédric Mombereau; Christoph Ziegenhain; Tanay Ghosh; Arnaud Cressant; Wolfgang Enard; Sylvie Granon; Joseph D Dougherty; Matthias Groszer
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

5.  Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Authors:  Eliezer Giladi; Joanna M Hill; Efrat Dresner; Conor M Stack; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007-10-02       Impact factor: 3.444

6.  Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior.

Authors:  Maria A Lim; Conor M Stack; Katrina Cuasay; Madeleine M Stone; Hewlet G McFarlane; James A Waschek; Joanna M Hill
Journal:  Int J Dev Neurosci       Date:  2008-03-14       Impact factor: 2.457

7.  Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death.

Authors:  Pawel Niewiadomski; Anne-Claire Coûté-Monvoisin; Catalina Abad; Danny Ngo; Adrian Menezes; James A Waschek
Journal:  J Mol Neurosci       Date:  2008-05-20       Impact factor: 3.444

8.  Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jonathan D Edwards; Arthur H M Burghes
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

9.  Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice.

Authors:  Conor M Stack; Maria A Lim; Katrina Cuasay; Madeleine M Stone; Kimberly M Seibert; Irit Spivak-Pohis; Jacqueline N Crawley; James A Waschek; Joanna M Hill
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

10.  Response to neonatal anesthesia: effect of sex on anatomical and behavioral outcome.

Authors:  S Rothstein; T Simkins; J L Nuñez
Journal:  Neuroscience       Date:  2008-02-05       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.